These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of vascularized allograft and xenograft rejection in rodents by brequinar sodium. Cramer DV; Chapman FA; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):23-8. PubMed ID: 8516938 [TBL] [Abstract][Full Text] [Related]
3. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394 [TBL] [Abstract][Full Text] [Related]
4. The development of Brequinar as an immunosuppressive drug for transplantation. Makowka L; Sher LS; Cramer DV Immunol Rev; 1993 Dec; 136():51-70. PubMed ID: 8132203 [TBL] [Abstract][Full Text] [Related]
5. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival. Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026 [TBL] [Abstract][Full Text] [Related]
7. Prevention of liver allograft rejection in rats by a short course of therapy with Brequinar Sodium. Cramer DV; Knoop M; Chapman FA; Wa GD; Jaffee BD; Makowka L Transplantation; 1992 Oct; 54(4):752-3. PubMed ID: 1412774 [No Abstract] [Full Text] [Related]
8. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945 [No Abstract] [Full Text] [Related]
9. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat. Knoop M; Cramer DV; Chapman FC; Makowka L Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719 [No Abstract] [Full Text] [Related]
10. The use of brequinar sodium for transplantation. Cramer DV; Chapman FA; Makowka L Ann N Y Acad Sci; 1993 Nov; 696():216-26. PubMed ID: 8109829 [No Abstract] [Full Text] [Related]
11. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine. Dunn JF; Hatch J; Precht A; Hart M; Li S Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479 [No Abstract] [Full Text] [Related]
12. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
13. Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection. Catena M; Woo J; Valdivia LA; Celli S; Pan F; Fung JJ; Starzl TE; Thompson AW Transplant Proc; 1994 Jun; 26(3):1288-9. PubMed ID: 8029911 [No Abstract] [Full Text] [Related]
14. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948 [No Abstract] [Full Text] [Related]
15. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression. Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706 [TBL] [Abstract][Full Text] [Related]
16. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214 [TBL] [Abstract][Full Text] [Related]
17. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059 [No Abstract] [Full Text] [Related]
18. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model. Murphy MP; Morris RE Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955 [No Abstract] [Full Text] [Related]
19. Brequinar in combination with cyclosporine a inhibits islet xenograft rejection for up to 24 days: a study in the pig-to-rat model. Wennberg L; Song Z; Wijkström M; Zhang J; Bari S; Sundberg B; Groth CG; Korsgren O Transplant Proc; 2000 Aug; 32(5):1026. PubMed ID: 10936333 [No Abstract] [Full Text] [Related]